The U.S. Defense Advanced Research Projects Agency (DARPA) has awarded Polaris Quantum Biotech (PolarisQB) an Embedded Entrepreneurship Initiative (EEI) grant to accelerate commercialization of its quantum computing platform for drug design. The funding follows earlier DARPA-backed research under the “Imagining Practical Applications for a Quantum Tomorrow” (IMPAQT) program, where the company applied quantum algorithms to identify small-molecule inhibitors against Ebola-related protein-protein interactions.

Read more here.